Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.82 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) Amortizatization of Intangibles (2010)

Updated

Lexicon Pharmaceuticals' Amortizatization of Intangibles was $3.96 million in FY2010, up 84.8% from $2.14 million in FY2009.

Analysis

Lexicon Pharmaceuticals (LXRX) Amortizatization of Intangibles (2010) Analysis & Trends

  • Per Business Quant data, Amortizatization of Intangibles in earlier years was $2.14 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amort. of Intangibles (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 984.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 600.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Lexicon Pharmaceuticals 813.30 Mn 239.86 Mn 653,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2010 2.60 Mn
API Access

Lexicon Pharmaceuticals Amortizatization of Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=LXRX&period=max&api_key=YOUR_API_KEY